Genetic and multi-omic prioritization implicates the CD33-SIGLEC locus in post-traumatic stress disorder
- 1Zhejiang University
Abstract
Genetic studies of post-traumatic stress disorder (PTSD) implicate immune regulation, yet linking peripheral immune-related proteins to brain molecular regulation and experimentally tractable targets remains challenging. Cellular and spatial genetic analyses were used to characterize the cellular and spatial genetic context of these traits. We then conducted bidirectional Mendelian randomization (MR) across 30 predefined Ig-like plasma proteins and 16 behavioral and neuropsychiatric traits. The forward MR screen identified four associations meeting the prespecified screening criteria, all of which underwent the same post-screening robustness assessment. CD33-PTSD showed the most consistent support across instrument definitions and applicable robust estimators and was therefore advanced as the prioritized candidate to regional genetic, brain molecular QTL, and functional analyses. Standard CD33 pQTL-PTSD colocalization did not support a simple shared single-variant model, while multi-signal analyses remained scientifically unresolved under the available LD reference. Meanwhile, plasma CD33 pQTL and cortical CD33 eQTL showed strong regional sharing (PP4=0.96468). Regional localization, cross-analysis candidate selection, and functional annotation further suggested a complex regulatory context across the CD33-SIGLEC region. Among 284 compounds with prior CD33 binding evidence that entered structure-assisted screening, 11 were retained as candidates for experimental follow-up. Overall, CD33-PTSD was the prioritized association identified by our screening; subsequent regional genetic, brain molecular QTL, and functional annotation analyses further delineated the complex regulatory context of the CD33- SIGLEC locus, while the CD33-centered structure-assisted exploration yielded 11 compound candidates for subsequent experimental validation.
Related
- Human genetic risk for major depressive disorder implicates motor cortex PVALB⁺ inhibitory neurons
- Genetic and Social Determinants of Post-Traumatic Stress Disorder: What Is Ready for Clinical Practice? A Critical Integrative Review
- A combined genetic and bioinformatic analysis implicates the CDKN1A rs1059234 variant in differentiated thyroid carcinoma susceptibility
- Progression GWAS followed by functional characterization implicates E3 ubiquitin ligase TRIM2 as a potential genetic modifier of Parkinson’s disease progression
- Rare coding variation implicates thirteen genes in bipolar disorder across 232,536 individuals from global populations
BibTeX
@misc{liu2026genetic,
title = {{Genetic and multi-omic prioritization implicates the CD33-SIGLEC locus in post-traumatic stress disorder}},
author = {H. Liu and S. Xie and Z. Chen and Q. Wang},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.23.26363743},
url = {https://www.medrxiv.org/content/10.64898/2026.09.23.26363743v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Genetic and multi-omic prioritization implicates the CD33-SIGLEC locus in post-traumatic stress disorder
AU - H. Liu
AU - S. Xie
AU - Z. Chen
AU - Q. Wang
PY - 2026
DA - 2026/09/23
PB - medRxiv
DO - 10.64898/2026.09.23.26363743
UR - https://www.medrxiv.org/content/10.64898/2026.09.23.26363743v1
AB - Genetic studies of post-traumatic stress disorder (PTSD) implicate immune regulation, yet linking peripheral immune-related proteins to brain molecular regulation and experimentally tractable targets remains challenging. Cellular and spatial genetic analyses were used to characterize the cellular and spatial genetic context of these traits. We then conducted bidirectional Mendelian randomization (MR) across 30 predefined Ig-like plasma proteins and 16 behavioral and neuropsychiatric traits. The forward MR screen identified four associations meeting the prespecified screening criteria, all of which underwent the same post-screening robustness assessment. CD33-PTSD showed the most consistent support across instrument definitions and applicable robust estimators and was therefore advanced as the prioritized candidate to regional genetic, brain molecular QTL, and functional analyses. Standard CD33 pQTL-PTSD colocalization did not support a simple shared single-variant model, while multi-signal analyses remained scientifically unresolved under the available LD reference. Meanwhile, plasma CD33 pQTL and cortical CD33 eQTL showed strong regional sharing (PP4=0.96468). Regional localization, cross-analysis candidate selection, and functional annotation further suggested a complex regulatory context across the CD33-SIGLEC region. Among 284 compounds with prior CD33 binding evidence that entered structure-assisted screening, 11 were retained as candidates for experimental follow-up. Overall, CD33-PTSD was the prioritized association identified by our screening; subsequent regional genetic, brain molecular QTL, and functional annotation analyses further delineated the complex regulatory context of the CD33- SIGLEC locus, while the CD33-centered structure-assisted exploration yielded 11 compound candidates for subsequent experimental validation.
ER -